Lexaria Bioscience Corp.
Pharmaceutical company · Kelowna, British Columbia, Canada · Nasdaq: LEXX
Lexaria Bioscience Corp. is a pharmaceutical company headquartered in Kelowna, British Columbia, Canada. Its shares trade on Nasdaq under the ticker LEXX. It has reported private securities offerings to the US SEC, most recently $3.5 million sold in a notice filed in 2025.
Lexaria Bioscience at a glance
What does Lexaria Bioscience do?
Private fundraising reported to the SEC
13 Form D notices; the most recent reported $3.5 million sold (2025).
Frequently asked questions about Lexaria Bioscience
Where is Lexaria Bioscience headquartered?
Lexaria Bioscience Corp. is headquartered in Kelowna, British Columbia, Canada.
What does Lexaria Bioscience do?
Lexaria Bioscience Corp. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Lexaria Bioscience a public company?
Yes. Lexaria Bioscience Corp. trades on Nasdaq under the ticker LEXX.
Similar companies
- Aurinia Pharmaceuticals Inc.Edmonton, Alberta, Canada
- AbCellera Biologics Inc.Vancouver, British Columbia, Canada
- Medicenna Therapeutics Corp.Toronto, Ontario, Canada
- Satellos Bioscience Inc.Markham, Ontario, Canada
- Edesa Biotech, Inc.Markham, Ontario, Canada
- Eupraxia Pharmaceuticals Inc.Vancouver, British Columbia, Canada
- InMed Pharmaceuticals Inc.Vancouver, British Columbia, Canada
- Clearmind Medicine Inc.Vancouver, British Columbia, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.